A detailed history of Semmax Financial Advisors Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 161 shares of LLY stock, worth $121,299. This represents 0.04% of its overall portfolio holdings.

Number of Shares
161
Previous 163 1.23%
Holding current value
$121,299
Previous $147,000 3.4%
% of portfolio
0.04%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $1,544 - $1,920
-2 Reduced 1.23%
161 $142,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 3.82%
163 $147,000
Q1 2024

May 16, 2024

BUY
$592.2 - $792.28 $43,822 - $58,628
74 Added 89.16%
157 $122,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $36,080 - $49,741
83 New
83 $44,000
Q2 2020

Jul 17, 2020

SELL
$136.42 - $164.18 $3,410 - $4,104
-25 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$119.05 - $147.35 $2,976 - $3,683
25 New
25 $3,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Semmax Financial Advisors Inc. Portfolio

Follow Semmax Financial Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.